Clinical trial Recruiting at 1 site Observational Ages 3 Days to 1 Week

Continuous skin temperature monitoring in newborns during therapeutic hypothermia

Official title: Continuous Monitoring of Body Temperature in Neonates During Therapeutic Hypothermia - A Prospective Observational Pilot Study

Run by Medical University of Graz · NCT07756892 · Data updated 2026-11-12

This study tests whether a wireless adhesive thermometer can safely and accurately monitor temperature in term and near-term newborns receiving therapeutic cooling.

More Hypoxic-Ischemic Encephalopathy trials

Quick facts

Study typeObservational
Ages3 Days to 1 Week
SexAll
Enrollment10 (estimated)
SponsorMedical University of Graz
Academic / other
Locations1 site (Graz, Styria)
StatusRecruiting
StartedAugust 5, 2026
Main results expectedAugust 15, 2028
Study endsAugust 15, 2028
Registry record updatedOctober 6, 2026
Trial IDNCT07756892 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Neonates born at 36 weeks gestation or more who require therapeutic hypothermia for hypoxic-ischemic encephalopathy and whose parents have provided informed consent.

Probably not a fit

Patients not meeting gestational age criteria or not requiring therapeutic hypothermia may not benefit, and some may not experience improved monitoring accuracy.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, single-center observational pilot evaluates the feasibility, accuracy, and safety of the SteadyTemp wireless adhesive thermometer for continuous non-invasive temperature monitoring in neonates undergoing therapeutic hypothermia for hypoxic-ischemic encephalopathy. Temperature will be recorded via the adhesive sensor on the right axilla for about 10 hours during rewarming, with simultaneous rectal measurements as the reference standard. The study compares the adhesive thermometer readings with core rectal temperatures and examines skin condition after device removal. Enrollment targets ten neonates born at ≥36 weeks’ gestation with a clinical indication for therapeutic hypothermia, under parental consent.

Why it matters

Potential benefit: If successful, this non-invasive method could reduce the need for invasive rectal probes and associated risks while providing reliable temperature monitoring during hypothermia.

How similar studies have gone: Prior work shows potential for wireless skin sensors in term neonates under normal temperatures, but this application during therapeutic hypothermia is novel and exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Neonates born at ≥36+0 weeks of gestation.
* Clinical indication for therapeutic hypothermia.
* Written informed consent obtained from the parents or legal guardians before study measurements are initiated.

Exclusion Criteria:

* Gestational age \<36+0 weeks.
* No clinical indication for therapeutic hypothermia.
* Written informed consent not obtained from the parents or legal guardians.
* Congenital malformation.

Where it's running

  • Medical University Graz
    Graz, Styria, Austria
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.